A medical staff member injects domestically produced bivalent HPV vaccine to a girl in Lianyungang, Jiangsu province, in May 2023. ZHU HUANAN/FOR CHINA DAILY To meet growing health needs ...

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the ...

H5 and N1 together, which is a bivalent vaccine, also provided complete protection, but it did not outperform H5 alone. Put another way, adding N1 did not offer more protection than H5 alone.

Moderna, meanwhile, also agreed with the EU to set back its planned deliveries so member states " will have the possibility to receive the expected updated bivalent booster candidate following ...

H5 and N1 together, which is a bivalent vaccine, also provided complete protection, but it did not outperform H5 alone. Put another way, adding N1 did not offer more protection than H5 alone.

NEW YORK, April 16, 2025--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices ...

The US Food and Drug Administration (FDA) has approved the monovalent Arexvy (GSK), Pfizer’s bivalent Abrysvo, and Moderna’s monovalent mRNA vaccine, mResvia, for adults over age 60.

The strongest protection against COVID-19 infection was observed among adults with hybrid immunity from prior infections and the bivalent vaccine, whereas vaccination alone conferred moderate ...

We are delighted to inform you that Panacea Biotec Ltd. has received an additional Award from UNICEF for supply of 40 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 5.20 million ...